INTRODUCTION: The objective of this study was to evaluate the effect of apolipoprotein E (APOE) epsilon 4 allele on regional cerebral perfusion (rCBF) changes using arterial spin labeling (ASL) magnetic resonance imaging (MRI) in subjects who are carriers or noncarriers of this risk factor for Alzheimer disease (AD). METHODS: Twenty-five subjects with AD, 25 with amnestic mild cognitive impairment (MCI) and 25 cognitively normal (CN) subjects underwent isotropic volumetric T1-weighted imaging and pulsed ASL MRI. All subjects were divided into carrier or noncarriers of the epsilon4 allele. Voxel-based statistical analyses were performed among groups on rCBF by ANOVA tests. In each subject group, we also evaluated the rCBF change between carrier and noncarrier groups. RESULTS: rCBF was significantly reduced in AD subjects compared to other subjects. In CN and AD subjects, rCBF in the carrier group was significantly reduced in several areas of the brain compared with that of the noncarrier group. In the carrier group, rCBF was significantly increased in the right parahippocampal gyrus, the bilateral cingulate gyri and the right posterior cingulate on the MCI group in addition to the right superior frontal gyrus in the AD group. CONCLUSION: rCBF in the CN and AD groups were significantly reduced in the subjects with the carriers of the epsilon4 allele, which is a risk factor for Alzheimer's disease. In addition, rCBF in the MCI group was significantly increased in subjects who were carriers. Therefore, rCBF can be used as a biomarker to show disease progression in areas of the brain of MCI subjects.
INTRODUCTION: The objective of this study was to evaluate the effect of apolipoprotein E (APOE) epsilon 4 allele on regional cerebral perfusion (rCBF) changes using arterial spin labeling (ASL) magnetic resonance imaging (MRI) in subjects who are carriers or noncarriers of this risk factor for Alzheimer disease (AD). METHODS: Twenty-five subjects with AD, 25 with amnestic mild cognitive impairment (MCI) and 25 cognitively normal (CN) subjects underwent isotropic volumetric T1-weighted imaging and pulsed ASL MRI. All subjects were divided into carrier or noncarriers of the epsilon4 allele. Voxel-based statistical analyses were performed among groups on rCBF by ANOVA tests. In each subject group, we also evaluated the rCBF change between carrier and noncarrier groups. RESULTS:rCBF was significantly reduced in AD subjects compared to other subjects. In CN and AD subjects, rCBF in the carrier group was significantly reduced in several areas of the brain compared with that of the noncarrier group. In the carrier group, rCBF was significantly increased in the right parahippocampal gyrus, the bilateral cingulate gyri and the right posterior cingulate on the MCI group in addition to the right superior frontal gyrus in the AD group. CONCLUSION:rCBF in the CN and AD groups were significantly reduced in the subjects with the carriers of the epsilon4 allele, which is a risk factor for Alzheimer's disease. In addition, rCBF in the MCI group was significantly increased in subjects who were carriers. Therefore, rCBF can be used as a biomarker to show disease progression in areas of the brain of MCI subjects.
Authors: W Jagust; R Thisted; M D Devous; R Van Heertum; H Mayberg; K Jobst; A D Smith; N Borys Journal: Neurology Date: 2001-04-10 Impact factor: 9.910
Authors: Ze Wang; Geoffrey K Aguirre; Hengyi Rao; Jiongjiong Wang; María A Fernández-Seara; Anna R Childress; John A Detre Journal: Magn Reson Imaging Date: 2007-09-10 Impact factor: 2.546
Authors: Yawu Liu; Teemu Paajanen; Eric Westman; Lars-Olof Wahlund; Andrew Simmons; Catherine Tunnard; Tomasz Sobow; Petroula Proitsi; John Powell; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Sebastian Muehlboeck; Alan Evans; Christian Spenger; Simon Lovestone; Hilkka Soininen Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: Gary W Small; Susan Y Bookheimer; Paul M Thompson; Greg M Cole; S-C Huang; Vladimir Kepe; Jorge R Barrio Journal: Lancet Neurol Date: 2008-02 Impact factor: 44.182
Authors: Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: Laura M Raffield; Amanda J Cox; Christina E Hugenschmidt; Barry I Freedman; Carl D Langefeld; Jeff D Williamson; Fang-Chi Hsu; Joseph A Maldjian; Donald W Bowden Journal: Neurobiol Aging Date: 2014-11-20 Impact factor: 4.673
Authors: Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Neurol Sci Date: 2014-02-18 Impact factor: 3.181
Authors: Maja A A Binnewijzend; Joost P A Kuijer; Wiesje M van der Flier; Marije R Benedictus; Christiane M Möller; Yolande A L Pijnenburg; Afina W Lemstra; Niels D Prins; Mike P Wattjes; Bart N M van Berckel; Philip Scheltens; Frederik Barkhof Journal: Eur Radiol Date: 2014-07-05 Impact factor: 5.315
Authors: Eric McDade; Albert Kim; Jeffrey James; Lei K Sheu; Dora Chieh-Hsin Kuan; Davneet Minhas; Peter J Gianaros; Snezana Ikonomovic; Oscar Lopez; Beth Snitz; Julie Price; Jim Becker; Chet Mathis; William Klunk Journal: Neurology Date: 2014-07-16 Impact factor: 9.910
Authors: Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu Journal: Acta Neuropathol Date: 2016-02-16 Impact factor: 17.088